These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11525847)

  • 21. Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors.
    Sato D; Kisen T; Kumagai M; Ohta K
    Bioorg Med Chem; 2018 Jan; 26(2):536-542. PubMed ID: 29274704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 10-Formyl-5,8,10-trideazafolic acid (10-formyl-TDAF): a potent inhibitor of glycinamide ribonucleotide transformylase.
    Boger DL; Haynes NE; Kitos PA; Warren MS; Ramcharan J; Marolewski AE; Benkovic SJ
    Bioorg Med Chem; 1997 Sep; 5(9):1817-30. PubMed ID: 9354237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of a tetrahydropyran-based inhibitor of mammalian ribonucleotide reductase.
    Smith AB; Sasho S; Barwis BA; Sprengeler P; Barbosa J; Hirschmann R; Cooperman BS
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3133-6. PubMed ID: 9873690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of N-hydroxy-N'-aminoguanidine derivatives as inhibitors of mammalian ribonucleotide reductase.
    Weckbecker G; Lien EJ; Cory JG
    Biochem Pharmacol; 1988 Feb; 37(3):529-34. PubMed ID: 3276327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the antiproliferative effects of tropolone derivatives in Jurkat T-lymphocyte cells.
    Ononye SN; Vanheyst MD; Giardina C; Wright DL; Anderson AC
    Bioorg Med Chem; 2014 Apr; 22(7):2188-93. PubMed ID: 24613456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural aspects of N-hydroxy-N'-aminoguanidine derivatives as inhibitors of L1210 cell growth and ribonucleotide reductase activity.
    Cory JG; Cory AH; Raber NK; Narayanan A; Schneller SW
    Adv Enzyme Regul; 1993; 33():129-40. PubMed ID: 8356905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and virtual screening towards synthesis of novel substituted thiosemicarbozones as ribonuleotide reductase (RNR) inhibitors with improved cellular trafficking and anticancer activity.
    Gokhale N; Jain S; Yadav M
    Curr Top Med Chem; 2015; 15(1):37-42. PubMed ID: 25579572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phototriggerable peptidomimetics for the inhibition of Mycobacterium tuberculosis ribonucleotide reductase by targeting protein-protein binding.
    Karlsson C; Blom M; Johansson M; Jansson AM; Scifo E; Karlén A; Govender T; Gogoll A
    Org Biomol Chem; 2015 Mar; 13(9):2612-21. PubMed ID: 25580895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel α-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis.
    Li J; Falcone ER; Holstein SA; Anderson AC; Wright DL; Wiemer AJ
    Pharmacol Res; 2016 Nov; 113(Pt A):438-448. PubMed ID: 27663262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of novel D- and L-3'-deoxy-3'-C-hydroxymethyl nucleoside with exocyclic methylene as potential ribonucleotide reductase inhibitor.
    Chun MW; Kim MJ; Jo UH; Kim JH; Kim HD; Jeong LS
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):703-6. PubMed ID: 11563096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
    Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
    Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. More potent linear peptide inhibitors of mammalian ribonucleotide reductase.
    Tan C; Gao Y; Kaur J; Cooperman BS
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5301-4. PubMed ID: 15454215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones.
    Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
    Biochem Pharmacol; 1994 Jul; 48(2):335-44. PubMed ID: 8053929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpes simplex virus ribonucleotide reductase subunit association inhibitors: the effect and conformation of beta-alkylated aspartic acid derivatives.
    Moss N; Déziel R; Ferland JM; Goulet S; Jones PJ; Leonard SF; Pitner TP; Plante R
    Bioorg Med Chem; 1994 Sep; 2(9):959-70. PubMed ID: 7712131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ribonucleotide reductase inhibitors and future drug design.
    Shao J; Zhou B; Chu B; Yen Y
    Curr Cancer Drug Targets; 2006 Aug; 6(5):409-31. PubMed ID: 16918309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of N-hydroxy-N'-aminoguanidine isoquinoline in combination with other inhibitors of ribonucleotide reductase on L1210 cells.
    Weckbecker G; Weckbecker A; Lien EJ; Cory JG
    J Natl Cancer Inst; 1988 Jun; 80(7):491-6. PubMed ID: 2452889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis.
    Furukawa T; Naitoh Y; Kohno H; Tokunaga R; Taketani S
    Life Sci; 1992; 50(26):2059-65. PubMed ID: 1608289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies.
    Tsimberidou AM; Alvarado Y; Giles FJ
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):437-48. PubMed ID: 12647987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-Guided Synthesis and Mechanistic Studies Reveal Sweetspots on Naphthyl Salicyl Hydrazone Scaffold as Non-Nucleosidic Competitive, Reversible Inhibitors of Human Ribonucleotide Reductase.
    Huff SE; Mohammed FA; Yang M; Agrawal P; Pink J; Harris ME; Dealwis CG; Viswanathan R
    J Med Chem; 2018 Feb; 61(3):666-680. PubMed ID: 29253340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarba-zone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs.
    Li J; Zheng LM; King I; Doyle TW; Chen SH
    Curr Med Chem; 2001 Feb; 8(2):121-33. PubMed ID: 11172670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.